Related Experiment Video
Updated: Dec 13, 2025

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19
George R Thompson Iii1,2, Oliver A Cornely3,4,5,6, Peter G Pappas7
1Department of Internal Medicine, University of California Davis Medical Center, Davis, California, USA.
Abstract:
Pulmonary aspergillosis has been increasingly reported following severe respiratory viral infections. Millions have been infected by SARS-CoV-2, placing large numbers of patients at-risk for COVID-19 associated pulmonary aspergillosis (CAPA). Prompt recognition of this syndrome and is paramount to improve outcomes.
Insights
Pulmonary aspergillosis is a growing concern after severe respiratory viral infections like COVID-19. Early identification of COVID-19 associated pulmonary aspergillosis (CAPA) is crucial for better patient outcomes.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Pulmonology
Background:
- Pulmonary aspergillosis incidence rises after severe respiratory viral infections.
- Millions infected with SARS-CoV-2 are at risk for COVID-19 associated pulmonary aspergillosis (CAPA).
Purpose of the Study:
- To highlight the increasing association between SARS-CoV-2 and pulmonary aspergillosis.
- To emphasize the critical need for prompt recognition of CAPA.
Main Methods:
- Review of recent clinical reports and epidemiological data.
- Analysis of risk factors and clinical presentation of CAPA.
Main Results:
- Significant increase in reported cases of pulmonary aspergillosis post-SARS-CoV-2 infection.
- CAPA identified as a serious complication in COVID-19 patients.
Conclusions:
- Early diagnosis and management of CAPA are essential.
- Increased vigilance for fungal co-infections in respiratory viral pandemics is warranted.
More Related Videos
09:52Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
15:01Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung
Published on: September 18, 2021
Related Concept Videos
Pneumonia II: Pathophysiology
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Pneumonia III: Complications and Assessment
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...